Hillsdale Investment Management’s Boston Scientific BSX Stock Holding History

Hillsdale Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,150	Closed	-$637K	–	667
2026 Q1	$637K	Buy	10,150 +1,500	+17%	+$120K	0.02%	415
2025 Q4	$825K	Buy	8,650 +100	+1%	+$9.8K	0.02%	411
2025 Q3	$835K	Buy	8,550 +1,600	+23%	+$166K	0.03%	397
2025 Q2	$747K	Buy	6,950 +900	+15%	+$91.1K	0.03%	350
2025 Q1	$610K	Sell	6,050 -2,450	-29%	-$247K	0.03%	337
2024 Q4	$759K	Buy	+8,500	New	+$748K	0.04%	293
2023 Q4	–	Sell	-10,400	Closed	-$549K	–	575
2023 Q3	$549K	Buy	10,400 +1,700	+20%	+$89.2K	0.05%	239
2023 Q2	$471K	Buy	+8,700	New	+$454K	0.04%	253

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hillsdale Investment Management's BSX Position: Q2 2026 in Review

Hillsdale Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 10,150 shares — an estimated $637K sold.

Hillsdale Investment Management first reported a position in BSX in Q2 2023 and held it in 8 quarters. The position peaked at $835K in Q3 2025. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Hillsdale Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Hillsdale Investment Management sold 10,150 Boston Scientific shares in Q2 2026, an estimated $637K.
Hillsdale Investment Management first reported a position in Boston Scientific in Q2 2023 and held it in 8 quarters.
Hillsdale Investment Management's Boston Scientific position peaked at $835K in Q3 2025.
1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.